Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Show more...
CEO
Mr. Goichi Matsuda
Çalışanlar
560
Ülke
Japonya
ISIN
JP3635800000
Kotasyonlar
0 Comments
Düşüncelerini paylaş
FAQ
Torii Pharmaceutical hissesinin bugünkü fiyatı nedir?▼
4551.TSE’un güncel fiyatı ¥12,222,797,500 JPY — son 24 saatte %+0.32% arttı. Torii Pharmaceutical hissesinin fiyat performansını grafikte daha yakından izle.
Torii Pharmaceutical hissesinin sembolü nedir?▼
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, borsasında Torii Pharmaceutical hisseleri 4551.TSE sembolüyle işlem görür.